OCWP
TEVA icon

Owl Creek Wealth Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Owl Creek Wealth Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Buy
923
+56
+6% +$1.86K 0.01% 506
2026
Q1 		$26.1K Buy
+867
New +$27.9K 0.01% 498

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Owl Creek Wealth Partners's TEVA Position: Q2 2026 in Review

Owl Creek Wealth Partners increased its Teva Pharmaceuticals (TEVA) stake by 6.5% in Q2 2026, buying an estimated $1.86K and bringing the position to 923 shares worth $31.3K. The position accounts for 0.01% of the portfolio, ranked #506.

Owl Creek Wealth Partners first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Owl Creek Wealth Partners held 923 shares of Teva Pharmaceuticals worth $31.3K as of Q2 2026.
  • Owl Creek Wealth Partners bought 56 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.86K.
  • Teva Pharmaceuticals made up 0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #506 holding.
  • Owl Creek Wealth Partners first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.